Zobrazeno 1 - 10 of 108 pro vyhledávání: '"MR Sertoli"'
1
Granulocyte-macrophage colony-stimulating factor (GM-CSF) allows acceleration and dose intensity increase of CEF chemotherapy: a randomised study in patients with advanced breast cancer
Autor: A Ardizzoni, M Venturini, MR Sertoli, PG Giannessi, F Brema, M Danova, F Testore, GL Mariani, MC Pennucci, P Queirolo, S Silvestro, P Bruzzi, R Lionetto, F Latini, R Rosso
Publikováno v: British Journal of Cancer
A randomised study was conducted in 62 patients with advanced breast cancer to assess whether granulocyte-macrophage colony-stimulating factor (GM-CSF) would yield an increase in the dose intensity of a standard-dose CEF regimen through an accelerati
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b7c4e2f79d538b407a946a0aab94e6d3
https://doi.org/10.1038/bjc.1994.71
Zobrazit plný text záznamu
2
Akademický článek
Concurrent versus sequential adjuvant chemo-endocrine therapy in hormone-receptor positive early stage breast cancer patients: a systematic review and meta-analysis.
Autor: Poggio F; Department of Medical Oncology, U.O. Oncologia Medica 2, IRCCS AOU San Martino - IST, Genova, Italy., Ceppi M; Unit of Clinical Epidemiology, IRCCS AOU San Martino-IST, Genova, Italy., Lambertini M; BrEAST Data Centre, Department of Medicine, Institut Jules Bordet, and l'Université Libre de Bruxelles (U.L.B.), Brussels, Belgium., Bruzzi P; Unit of Clinical Epidemiology, IRCCS AOU San Martino-IST, Genova, Italy., Ugolini D; Department of Internal Medicine, University of Genoa, Unit of Clinical Epidemiology, IRCCS AOU San Martino-IST, Genova, Italy., Bighin C; Department of Medical Oncology, U.O. Oncologia Medica 2, IRCCS AOU San Martino - IST, Genova, Italy., Levaggi A; Department of Medical Oncology, U.O. Sviluppo Terapie Innovative, IRCCS AOU San Martino - IST, Genova, Italy., Giraudi S; Department of Medical Oncology, U.O. Sviluppo Terapie Innovative, IRCCS AOU San Martino - IST, Genova, Italy., D'Alonzo A; Department of Medical Oncology, U.O. Sviluppo Terapie Innovative, IRCCS AOU San Martino - IST, Genova, Italy., Vaglica M; Department of Medical Oncology, U.O. Sviluppo Terapie Innovative, IRCCS AOU San Martino - IST, Genova, Italy., Blondeaux E; Department of Medical Oncology, U.O. Oncologia Medica 2, IRCCS AOU San Martino - IST, Genova, Italy., Sertoli MR; Department of Medical Oncology, Clinica di Oncologia Medica, IRCCS AOU San Martino - IST, Genova, Italy., Pronzato P; Department of Medical Oncology, U.O. Oncologia Medica 2, IRCCS AOU San Martino - IST, Genova, Italy., Del Mastro L; Department of Medical Oncology, U.O. Sviluppo Terapie Innovative, IRCCS AOU San Martino - IST, Genova, Italy. Electronic address: lucia.delmastro@hsanmartino.it.
Publikováno v: Breast (Edinburgh, Scotland) [Breast] 2017 Jun; Vol. 33, pp. 104-108. Date of Electronic Publication: 2017 Mar 27.
Zobrazit plný text záznamu
3
Akademický článek
Time trends in incidence rates and survival of newly diagnosed stage IV breast cancer by tumor histology: a population-based analysis.
Autor: Di Meglio A; Department of Medical Oncology, Dana-Farber Cancer Institute, 450 Brookline Avenue, Boston, MA, 02215, USA.; Academic Unit of Medical Oncology, IRCCS AOU San Martino University Hospital, IST National Cancer Research Institute, Genoa, Italy., Freedman RA; Department of Medical Oncology, Dana-Farber Cancer Institute, 450 Brookline Avenue, Boston, MA, 02215, USA., Lin NU; Department of Medical Oncology, Dana-Farber Cancer Institute, 450 Brookline Avenue, Boston, MA, 02215, USA., Barry WT; Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Boston, MA, USA., Metzger-Filho O; Department of Medical Oncology, Dana-Farber Cancer Institute, 450 Brookline Avenue, Boston, MA, 02215, USA., Keating NL; Department of Health Care Policy, Harvard Medical School, Boston, MA, USA.; Division of General Internal Medicine, Brigham and Women's Hospital, Boston, MA, USA., King TA; Department of Surgical Oncology, Dana-Farber Cancer Institute, Brigham and Women's Hospital, Boston, MA, USA., Sertoli MR; Academic Unit of Medical Oncology, IRCCS AOU San Martino University Hospital, IST National Cancer Research Institute, Genoa, Italy., Boccardo F; Academic Unit of Medical Oncology, IRCCS AOU San Martino University Hospital, IST National Cancer Research Institute, Genoa, Italy., Winer EP; Department of Medical Oncology, Dana-Farber Cancer Institute, 450 Brookline Avenue, Boston, MA, 02215, USA., Vaz-Luis I; Department of Medical Oncology, Dana-Farber Cancer Institute, 450 Brookline Avenue, Boston, MA, 02215, USA. InesV_Luis@dfci.harvard.edu.
Publikováno v: Breast cancer research and treatment [Breast Cancer Res Treat] 2016 Jun; Vol. 157 (3), pp. 587-96. Date of Electronic Publication: 2016 Jun 06.
Zobrazit plný text záznamu
4
Akademický článek
Ovarian Suppression With Triptorelin During Adjuvant Breast Cancer Chemotherapy and Long-term Ovarian Function, Pregnancies, and Disease-Free Survival: A Randomized Clinical Trial.
Autor: Lambertini M; Department of Medical Oncology, U.O. Oncologia Medica A, IRCCS AOU San Martino-IST, Istituto Nazionale per la Ricerca sul Cancro, Genova, Italy., Boni L; Centro Coordinamento Sperimentazioni Cliniche, AOU Careggi and Istituto Toscano Tumori, Firenze, Italy., Michelotti A; U. O. Oncologia Medica I, Ospedale S. Chiara, Dipartimento di oncologia, dei trapianti e delle nuove tecnologie, Azienda Ospedaliera Universitaria Pisana, Pisa, Italy., Gamucci T; Oncology Department, Ospedale S.S. Trinità, Sora, Italy., Scotto T; U. O. Oncologia Medica, Ospedale Civile, Sassari, Italy., Gori S; S. C. Oncologia Medica, Ospedale Santa Maria della Misericordia, Perugia, Italy7U. O. C. Oncologia Medica, Ospedale Sacro Cuore-Don Calabria, Negrar-Verona, Italy., Giordano M; S. C. di Oncologia, Azienda Ospedaliera S. Anna, Como, Italy., Garrone O; Dipartimento di Oncologia, Ospedale di Insegnamento S. Croce e Carle, Cuneo, Italy., Levaggi A; Department of Medical Oncology, U. O. Sviluppo Terapie Innovative, IRCCS AOU San Martino-IST, Istituto Nazionale per la Ricerca sul Cancro, Genova, Italy., Poggio F; Department of Medical Oncology, U.O. Oncologia Medica A, IRCCS AOU San Martino-IST, Istituto Nazionale per la Ricerca sul Cancro, Genova, Italy., Giraudi S; Department of Medical Oncology, U. O. Sviluppo Terapie Innovative, IRCCS AOU San Martino-IST, Istituto Nazionale per la Ricerca sul Cancro, Genova, Italy., Bighin C; Department of Medical Oncology, U.O. Oncologia Medica A, IRCCS AOU San Martino-IST, Istituto Nazionale per la Ricerca sul Cancro, Genova, Italy., Vecchio C; Department of Surgical Oncology, Chirurgia Senologica U1E, IRCCS AOU San Martino-IST, Istituto Nazionale per la Ricerca sul Cancro, Genova, Italy., Sertoli MR; Department of Medical Oncology, Clinica di Oncologia Medica, IRCCS AOU San Martino-IST, Istituto Nazionale per la Ricerca sul Cancro, Genova., Pronzato P; Department of Medical Oncology, U.O. Oncologia Medica A, IRCCS AOU San Martino-IST, Istituto Nazionale per la Ricerca sul Cancro, Genova, Italy., Del Mastro L; Department of Medical Oncology, U. O. Sviluppo Terapie Innovative, IRCCS AOU San Martino-IST, Istituto Nazionale per la Ricerca sul Cancro, Genova, Italy.
Publikováno v: JAMA [JAMA] 2015 Dec 22-29; Vol. 314 (24), pp. 2632-40.
Zobrazit plný text záznamu
5
Akademický článek
CXCR3/CCR5 pathways in metastatic melanoma patients treated with adoptive therapy and interleukin-2.
Autor: Bedognetti D; 1] Infectious Disease and Immunogenetics Section (IDIS), Department of Transfusion Medicine, Clinical Center and trans-NIH Center for Human Immunology (CHI), National Institutes of Health, Bethesda, MD 20892, USA [2] Department of Oncology, Biology, Genetics (DOBIG), University of Genoa and National Cancer Research Institute, 16132 Genoa, Italy [3] Department of Internal Medicine (DiMI), University of Genoa, 16132 Genoa, Italy., Spivey TL, Zhao Y, Uccellini L, Tomei S, Dudley ME, Ascierto ML, De Giorgi V, Liu Q, Delogu LG, Sommariva M, Sertoli MR, Simon R, Wang E, Rosenberg SA, Marincola FM
Publikováno v: British journal of cancer [Br J Cancer] 2013 Oct 29; Vol. 109 (9), pp. 2412-23. Date of Electronic Publication: 2013 Oct 15.
Zobrazit plný text záznamu
7
Akademický článek
Concurrent vs sequential adjuvant chemotherapy and hormone therapy in breast cancer: a multicenter randomized phase III trial.
Autor: Bedognetti D; Infectious Disease and Immunogenetics Section (IDIS), Department of Transfusion Medicine, Clinical Center, National Institutes of Health, 10 Center Drive, Bethesda, MD 20892, USA. bedodav@yahoo.it, Sertoli MR, Pronzato P, Del Mastro L, Venturini M, Taveggia P, Zanardi E, Siffredi G, Pastorino S, Queirolo P, Gardin G, Wang E, Monzeglio C, Boccardo F, Bruzzi P
Publikováno v: Journal of the National Cancer Institute [J Natl Cancer Inst] 2011 Oct 19; Vol. 103 (20), pp. 1529-39. Date of Electronic Publication: 2011 Sep 15.
Zobrazit plný text záznamu
8
Akademický článek
Impaired response to influenza vaccine associated with persistent memory B cell depletion in non-Hodgkin's lymphoma patients treated with rituximab-containing regimens.
Autor: Bedognetti D; Department of Oncology, Biology, and Genetics, University of Genoa, 16132 Genoa, Italy. davide.bedognetti@nih.gov, Zoppoli G, Massucco C, Zanardi E, Zupo S, Bruzzone A, Sertoli MR, Balleari E, Racchi O, Messina M, Caltabiano G, Icardi G, Durando P, Marincola FM, Boccardo F, Ferrarini M, Ansaldi F, De Maria A
Publikováno v: Journal of immunology (Baltimore, Md. : 1950) [J Immunol] 2011 May 15; Vol. 186 (10), pp. 6044-55. Date of Electronic Publication: 2011 Apr 15.
Zobrazit plný text záznamu
9
Akademický článek
Bevacizumab plus fotemustine as first-line treatment in metastatic melanoma patients: clinical activity and modulation of angiogenesis and lymphangiogenesis factors.
Autor: Del Vecchio M; Unit of Medical Oncology 2, Department of Medical Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Mortarini R, Canova S, Di Guardo L, Pimpinelli N, Sertoli MR, Bedognetti D, Queirolo P, Morosini P, Perrone T, Bajetta E, Anichini A
Publikováno v: Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2010 Dec 01; Vol. 16 (23), pp. 5862-72. Date of Electronic Publication: 2010 Oct 28.
Zobrazit plný text záznamu
10
Akademický článek
Gene-expression profiling in vaccine therapy and immunotherapy for cancer.
Autor: Bedognetti D; Infectious Disease and Immunogenetics Section, Department of Transfusion Medicine, Clinical Center, and Trans-NIH Center for Human Immunology, National Institutes of Health, Bethesda, MD 20892, USA., Wang E, Sertoli MR, Marincola FM
Publikováno v: Expert review of vaccines [Expert Rev Vaccines] 2010 Jun; Vol. 9 (6), pp. 555-65.
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje